Search Results

There are 21158 results for: content related to: A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia

  1. Actual and Potential Drug Interactions Associated with Methadone

    Pain Medicine

    Volume 9, Issue 3, April 2008, Pages: 315–344, Douglas J. Weschules, Kevin T. Bain and Steven Richeimer

    Version of Record online : 12 FEB 2007, DOI: 10.1111/j.1526-4637.2006.00289.x

  2. You have free access to this content
    The role of methadone in cancer pain treatment – a review

    International Journal of Clinical Practice

    Volume 63, Issue 7, July 2009, Pages: 1095–1109, W. Leppert

    Version of Record online : 22 JUN 2009, DOI: 10.1111/j.1742-1241.2008.01990.x

  3. Methadone Toxicity Fatalities: A Review of Medical Examiner Cases in a Large Metropolitan Area

    Journal of Forensic Sciences

    Volume 52, Issue 6, November 2007, Pages: 1389–1395, Lisa B.E. Shields, John C. Hunsaker III, Tracey S. Corey, Michael K. Ward and Donna Stewart

    Version of Record online : 10 DEC 2007, DOI: 10.1111/j.1556-4029.2007.00565.x

  4. You have free access to this content
    Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-hα7 cells by activating neuronal nicotinic acetylcholine receptors

    Journal of Neurochemistry

    Volume 94, Issue 5, September 2005, Pages: 1329–1341, Jukka S. Pakkanen, Heli Nousiainen, Jari Yli-Kauhaluoma, Irene Kylänlahti, Tommi Möykkynen, Esa R. Korpi, Jian-Hong Peng, Ronald J. Lukas, Liisa Ahtee and Raimo K. Tuominen

    Version of Record online : 5 JUL 2005, DOI: 10.1111/j.1471-4159.2005.03279.x

  5. You have free access to this content
    Methadone at tapered doses for the management of opioid withdrawal

    Intervention Review

    The Cochrane Library

    Laura Amato, Marina Davoli, Silvia Minozzi, Eliana Ferroni, Robert Ali and Marica Ferri

    Published Online : 28 FEB 2013, DOI: 10.1002/14651858.CD003409.pub4

  6. Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics: I. Evidence Against CYP3A Mediation of Methadone Clearance

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 4, October 2008, Pages: 497–505, ED Kharasch, PS Bedynek, S Park, D Whittington, A Walker and C Hoffer

    Version of Record online : 9 JUL 2008, DOI: 10.1038/clpt.2008.104

  7. Methadone for chronic non-cancer pain in adults

    Intervention Review

    The Cochrane Library

    Simon Haroutounian, Ewan D McNicol and Arthur G Lipman

    Published Online : 14 NOV 2012, DOI: 10.1002/14651858.CD008025.pub2

  8. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

    Clinical Pharmacology & Therapeutics

    Volume 76, Issue 3, September 2004, Pages: 250–269, Evan D. Kharasch, Christine Hoffer, Dale Whittington and Pamela Sheffels

    Version of Record online : 4 SEP 2004, DOI: 10.1016/j.clpt.2004.05.003

  9. Methadone for neuropathic pain in adults

    Intervention Review

    The Cochrane Library

    Ewan D McNicol, McKenzie C Ferguson and Roman Schumann

    Published Online : 17 MAY 2017, DOI: 10.1002/14651858.CD012499.pub2

  10. Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 4, April 2012, Pages: 673–684, E D Kharasch, D Whittington, D Ensign, C Hoffer, P S Bedynek, S Campbell, K Stubbert, A Crafford, A London and T Kim

    Version of Record online : 7 MAR 2012, DOI: 10.1038/clpt.2011.276

  11. You have free access to this content
    Post-marketing Surveillance of Methadone and Buprenorphine in the United States

    Pain Medicine

    Volume 11, Issue 7, July 2010, Pages: 1078–1091, Nabarun Dasgupta, Elise J. Bailey, Theodore Cicero, James Inciardi, Mark Parrino, Andrew Rosenblum and Richard C. Dart

    Version of Record online : 8 JUN 2010, DOI: 10.1111/j.1526-4637.2010.00877.x

  12. Unintentional methadone-related overdose death in New Mexico (USA) and implications for surveillance, 1998–2002

    Addiction

    Volume 100, Issue 2, February 2005, Pages: 176–188, Nina Shah, Sarah L. Lathrop and Michael G. Landen

    Version of Record online : 13 DEC 2004, DOI: 10.1111/j.1360-0443.2004.00956.x

  13. You have free access to this content
    Indicators of Buprenorphine and Methadone Use and Abuse: What Do We Know?

    The American Journal on Addictions

    Volume 19, Issue 1, January - February 2010, Pages: 73–88, Jane Carlisle Maxwell and Elinore F. McCance-Katz

    Version of Record online : 14 DEC 2009, DOI: 10.1111/j.1521-0391.2009.00008.x

  14. You have free access to this content
    Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity

    British Journal of Clinical Pharmacology

    Volume 79, Issue 6, June 2015, Pages: 967–977, Stéphane Mouly, Vanessa Bloch, Katell Peoc'h, Pascal Houze, Laurence Labat, Kamilia Ksouda, Guy Simoneau, Xavier Declèves, Jean Francois Bergmann, Jean-Michel Scherrmann, Jean-Louis Laplanche, Jean-Pierre Lepine and Florence Vorspan

    Version of Record online : 22 MAY 2015, DOI: 10.1111/bcp.12576

  15. Methadone for cancer pain

    Intervention Review

    The Cochrane Library

    Alexander B Nicholson, Graeme R Watson, Sheena Derry and Philip J Wiffen

    Published Online : 8 FEB 2017, DOI: 10.1002/14651858.CD003971.pub4

  16. You have free access to this content
    Pharmacological maintenance treatments of opiate addiction

    British Journal of Clinical Pharmacology

    Volume 77, Issue 2, February 2014, Pages: 253–263, James Bell

    Version of Record online : 22 JAN 2014, DOI: 10.1111/bcp.12051

  17. You have free access to this content
    Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    Intervention Review

    The Cochrane Library

    Richard P Mattick, Courtney Breen, Jo Kimber and Marina Davoli

    Published Online : 6 FEB 2014, DOI: 10.1002/14651858.CD002207.pub4

  18. The Effects of Once-Daily Saquinavir/Minidose Ritonavir on the Pharmacokinetics of Methadone

    The Journal of Clinical Pharmacology

    Volume 44, Issue 3, March 2004, Pages: 293–304, Dr Mark J. Shelton, Ms Denise Cloen, Ms Robin DiFrancesco, Dr Charles S. Berenson, Dr Andrew Esch, Dr Pascal J. de Caprariis, Ms Branka Palic, Ms Jane L. Schur, Mr Christopher J. L. Buggé, Mr Anders Ljungqvist, Mr Orlando Espinosa and Dr Ross G. Hewitt

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003262956

  19. ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment

    Clinical Pharmacology & Therapeutics

    Volume 80, Issue 6, December 2006, Pages: 668–681, Séverine Crettol, Jean-Jacques Déglon, Jacques Besson, Marina Croquette-Krokar, Robert Hämmig, Isabelle Gothuey, Martine Monnat and Chin B. Eap

    Version of Record online : 15 DEC 2006, DOI: 10.1016/j.clpt.2006.09.012

  20. Uses of Diverted Methadone and Buprenorphine by Opioid-Addicted Individuals in Baltimore, Maryland

    The American Journal on Addictions

    Volume 18, Issue 5, September-October 2009, Pages: 346–355, Shannon Gwin Mitchell, Sharon M. Kelly, Barry S. Brown, Heather Schacht Reisinger, James A. Peterson, Adrienne Ruhf, Michael H. Agar, Kevin E. O'Grady and Robert P. Schwartz

    Version of Record online : 18 FEB 2010, DOI: 10.1080/10550490903077820